Physician profile
David J Backstein
NPI 1982473641
$199,345.12
in general payments reported to CMS, 2019-2025
9 companies · $90K in 2025
The $90K reported for 2025 was more than what 91% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $192 · 2024: $109K · 2025: $90K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $87K · Consulting Fee: $53K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50K · Travel and Lodging: $5,597 · Food and Beverage: $4,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $86,599.38 |
| Consulting Fee | $53,250.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $49,887.06 |
| Travel and Lodging | $5,596.91 |
| Food and Beverage | $4,010.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microport Orthopedics INC | $182,926.20 | 2024-2025 | Mpo Medial Pivot Knee, Mpo Hip System |
| Medical Device Business Services, INC. | $11,039.00 | 2024-2025 | Attune, Velys |
| Arthrex, INC. | $4,119.45 | 2024-2025 | Arthrex |
| Depuy Synthes Sales INC. | $736.08 | 2024-2025 | Attune |
| Linkbio Corp | $192.34 | 2023 | |
| Innovation Technologies INC | $136.37 | 2025 | Irrisept |
| Zimmer Biomet Holdings, INC. | $111.63 | 2024 | Rosa |
| Heraeus Medical, LLC. | $84.05 | 2025 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4,416.92 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Backstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.